Related references
Note: Only part of the references are listed.Leucine Signals to mTORC1 via Its Metabolite Acetyl-Coenzyme A
Sung Min Son et al.
CELL METABOLISM (2019)
Common genetic variation drives molecular heterogeneity in human iPSCs
Helena Kilpinen et al.
NATURE (2017)
Autophagy and Neurodegeneration: Pathogenic Mechanisms and Therapeutic Opportunities
Fiona M. Menzies et al.
NEURON (2017)
A152T tau allele causes neurodegeneration that can be ameliorated in a zebrafish model by autophagy induction
Ana Lopez et al.
BRAIN (2017)
Expression of A152T human tau causes age-dependent neuronal dysfunction and loss in transgenic mice
Sumihiro Maeda et al.
EMBO REPORTS (2016)
Activation of tyrosine kinase c-Abl contributes to α-synuclein-induced neurodegeneration
Saurav Brahmachari et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
CCT complex restricts neuropathogenic protein aggregation via autophagy
Mariana Pavel et al.
NATURE COMMUNICATIONS (2016)
siRNA screen identifies QPCT as a druggable target for Huntington's disease
Maria Jimenez-Sanchez et al.
NATURE CHEMICAL BIOLOGY (2015)
Calpain inhibition mediates autophagy-dependent protection against polyglutamine toxicity
F. M. Menzies et al.
CELL DEATH AND DIFFERENTIATION (2015)
Antihypertensive Agents and Risk of Parkinson's Disease: A Nationwide Cohort Study
Yen-Chieh Lee et al.
PLOS ONE (2014)
PICALM modulates autophagy activity and tau accumulation
Kevin Moreau et al.
NATURE COMMUNICATIONS (2014)
A systematic genome-wide analysis of zebrafish protein-coding gene function
Ross N. W. Kettleborough et al.
NATURE (2013)
Monitoring autophagic flux by an improved tandem fluorescent-tagged LC3 (mTagRFP-mWasabi-LC3) reveals that high-dose rapamycin impairs autophagic flux in cancer cells
Cuihong Zhou et al.
AUTOPHAGY (2012)
PARIS (ZNF746) Repression of PGC-1α Contributes to Neurodegeneration in Parkinson's Disease
Joo-Ho Shin et al.
CELL (2011)
Unclassifiable tauopathy associated with an A152T variation in MAPT exon 7
G. G. Kovacs et al.
CLINICAL NEUROPATHOLOGY (2011)
Dopamine neurons derived from human ES cells efficiently engraft in animal models of Parkinson's disease
Sonja Kriks et al.
NATURE (2011)
Rilmenidine attenuates toxicity of polyglutamine expansions in a mouse model of Huntington's disease
Claudia Rose et al.
HUMAN MOLECULAR GENETICS (2010)
Sex-dependent effect of BAG1 in ameliorating motor deficits of Huntington disease transgenic mice
Adam L. Orr et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2008)
Novel targets for Huntington's disease in an mTOR-independent autophagy pathway
Andrea Williams et al.
NATURE CHEMICAL BIOLOGY (2008)
Dissection of the autophagosome maturation process by a novel reporter protein, tandem fluorescent-tagged LC3
Shunsuke Kimura et al.
AUTOPHAGY (2007)
Targeting neural circuitry in zebrafish using GAL4 enhancer trapping
Ethan K. Scott et al.
NATURE METHODS (2007)
Rapamycin alleviates toxicity of different aggregate-prone proteins
Z Berger et al.
HUMAN MOLECULAR GENETICS (2006)
Tau suppression in a neurodegenerative mouse model improves memory function
K SantaCruz et al.
SCIENCE (2005)
Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease
B Ravikumar et al.
NATURE GENETICS (2004)
α-synuclein is degraded by both autophagy and the proteasome
JL Webb et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53→Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice
MK Lee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy
B Ravikumar et al.
HUMAN MOLECULAR GENETICS (2002)
Share Paper
